Reciprocal regulation of cephalosporin resistance in Enterococcus faecalis

mBio

Volumn 2, Issue 6, 2011, Pages

  Kristich, Christopher J ^a   Little, Jaime L ^a   Hall, Cherisse L ^a   Hoff, Jessica S ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BACITRACIN; BACTERIAL PROTEIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CHLORAMPHENICOL; CYCLOSERINE; IREK PROTEIN; IREP PROTEIN; KANAMYCIN; NORFLOXACIN; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL; BACTERIAL GENE; BACTERIUM MUTANT; CELL FUNCTION; CONTROLLED STUDY; DRUG TARGETING; ENTEROCOCCUS FAECALIS; ENZYME ACTIVITY; GENETIC VARIABILITY; IN VITRO STUDY; IREK GENE; IREP GENE; MOLECULAR EVOLUTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ENTEROCOCCUS; ENTEROCOCCUS FAECALIS;

EID: 84855219477     PISSN: None     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00199-11     Document Type: Article

References (45)

1. Tannock GW, Cook G. 2002. Enterococci as members of the intestinal microflora of humans, p 101-132. In Gilmore MS, et al., (ed.), The Enterococci: pathogenesis, molecular biology, and antibiotic resistance. American Society for Microbiology Press, Washington, DC.
2. Hidron AI, et al. 2008. NHSN annual update: antimicrobial-resistant pathogens associated with health care-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect. Contr. Hosp. Epidemiol. 29:996-1011.
3. Shepard BD, Gilmore MS. 2002. Antibiotic-resistant enterococci: the mechanisms and dynamics of drug introduction and resistance. Microbes Infect. 4:215-224.
4. Donskey CJ, et al. 2000. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N. Engl. J. Med. 343:1925-1932.
5. Canepari P, Lleo MM, Cornaglia G, Fontana R, Satta G. 1986. In Streptococcus faecium penicillin-binding protein 5 alone is sufficient for growth at sub-maximal but not at maximal rate. J. Gen. Microbiol. 132: 625-631.
6. Signoretto C, Boaretti M, Canepari P. 1994. Cloning, sequencing and expression in Escherichia coli of the low-affinity penicillin binding protein of Enterococcus faecalis. FEMS Microbiol. Lett. 123:99-106.
7. Hancock LE, Perego M. 2004. Systematic inactivation and phenotypic characterization of two-component signal transduction systems of En-terococcus faecalis V583. J. Bacteriol. 186:7951-7958.
8. Comenge Y, et al. 2003. The CroRS two-component regulatory system is required for intrinsic beta-lactam resistance in Enterococcus faecalis. J. Bacteriol. 185:7184-7192.
9. Kristich CJ, Wells CL, Dunny GM. 2007. A eukaryotic-type Ser/Thr kinase inEnterococcus faecalis mediates antimicrobial resistance and intestinal persistence. Proc. Natl. Acad. Sci. U. S. A. 104:3508-3513.
10. Maestro B, et al. 2011. Recognition of peptidoglycan and beta-lactam antibiotics by the extracellular domain of the Ser/Thr protein kinase StkP from Streptococcus pneumoniae. FEBS Lett. 585:357-363.
11. Shah IM, Laaberki MH, Popham DL, Dworkin J. 2008. A eukaryotic-like Ser/Thr kinase signals bacteria to exit dormancy in response to pepti-doglycan fragments. Cell 135:486-496.
12. Mir M, et al. 2011. The extracytoplasmic domain of the Mycobacterium tuberculosis Ser/Thr kinase PknB binds specific muropeptides and is required for PknB localization. PLoS Pathog. 7:e1002182.
13. Pereira SF, Goss L, Dworkin J. 2011. Eukaryote-like serine/threonine kinases and phosphatases in bacteria. Microbiol. Mol. Biol. Rev. 75: 192-212.
14. Young TA, Delagoutte B, Endrizzi JA, Falick AM, Alber T. 2003. Structure of Mycobacterium tuberculosis PknB supports a universal activation mechanism for Ser/Thr protein kinases. Nat. Struct. Biol. 10: 168-174.
15. Ortiz-Lombardía M, Pompeo F, Boitel B, Alzari PM. 2003. Crystal structureof the catalytic domainofthe PknB serine/threonine kinase from Mycobacterium tuberculosis. J. Biol. Chem. 278:13094-13100.
16. Lombana TN, et al. 2010. Allosteric activation mechanism of the Myco-bacterium tuberculosis receptor Ser/Thr protein kinase, PknB. Structure 18:1667-1677.
17. Boitel B, et al. 2003. PknB kinase activity is regulated by phosphorylation in two Thr residues and dephosphorylation byPstP, the cognate phospho-Ser/Thr phosphatase, in Mycobacterium tuberculosis. Mol. Microbiol. 49: 1493-1508.
18. Madec E, et al. 2003. Mass spectrometry and site-directed mutagenesis identify several autophosphorylated residues required for the activity of PrkC, a Ser/Thr kinase from Bacillus subtilis. J. Mol. Biol. 330:459-472.
19. Durán R, et al. 2005. Conserved autophosphorylation pattern in activation loops and juxtamembrane regions of Mycobacterium tuberculosis Ser/Thr protein kinases. Biochem. Biophys. Res. Commun. 333:858-867.
20. Rajagopal L, Clancy A, Rubens CE. 2003. A eukaryotic type serine/ threonine kinase and phosphatase in Streptococcus agalactiae reversibly phosphorylate an inorganic pyrophosphatase and affect growth, cell segregation, and virulence. J. Biol. Chem. 278:14429-14441.
21. Jin H, Pancholi V. 2006. Identification and biochemical characterization of a eukaryotic-type serine/threonine kinase and its cognate phosphatase in Streptococcus pyogenes: their biological functions and substrate identification. J. Mol. Biol. 357:1351-1372.
22. Madec E, Laszkiewicz A, Iwanicki A, Obuchowski M, Séror S. 2002. Characterization of a membrane-linked Ser/Thr protein kinase in Bacillus subtilis, implicated in developmental processes. Mol. Microbiol. 46: 571-586.
23. Beltramini AM, Mukhopadhyay CD, Pancholi V. 2009. Modulation of cell wall structure and antimicrobial susceptibility by a Staphylococcus au-reus eukaryote-like serine/threonine kinase and phosphatase. Infect. Im-mun. 77:1406-1416.
24. Gaidenko TA, Kim TJ, Price CW. 2002. The PrpC serine-threonine phosphatase and PrkC kinase have opposing physiological roles in stationary-phase Bacillus subtilis cells. J. Bacteriol. 184:6109-6114.
25. Burnside K, et al. 2010. Regulation of hemolysin expression and virulence of Staphylococcus aureus by a Serine/threonine kinase and phosphatase. PLoS One 5:e11071.
26. Shah IM, Dworkin J. 2010. Induction and regulation of a secreted pep-tidoglycan hydrolase by a membrane Ser/Thr kinase that detects muro-peptides. Mol. Microbiol. 75:1232-1243.
27. Osaki M, et al. 2009. The StkP/PhpP signaling couple in Streptococcus pneumoniae: cellular organization and physiological characterization. J. Bacteriol. 191:4943-4950.
28. Kang CM, et al. 2005. The Mycobacterium tuberculosis serine/threonine kinases PknA and PknB: substrate identification and regulation of cell shape. Genes Dev. 19:1692-1704.
29. Nováková L, et al. 2005. Characterization of a eukaryotic type serine/ threonine protein kinase and protein phosphatase of Streptococcus pneu-moniae and identification of kinase substrates. FEBS J. 272:1243-1254.
30. Absalon C, et al. 2009. CpgA, EF-Tu and the stressosome protein YezB are substrates of the Ser/Thr kinase/phosphatase couple, PrkC/PrpC, in Bacillus subtilis. Microbiology 155:932-943.
31. McBride SM, Fischetti VA, Leblanc DJ, Moellering RC, Jr, Gilmore MS. 2007. Genetic diversity among Enterococcus faecalis. PLoS One 2:e582.
32. Bourgogne A, et al. 2008. Large scale variation in Enterococcus faecalis illustrated by the genome analysis of strain OG1RF. Genome Biol. 9:R110.
33. Palmer KL, et al. 2010. High-quality draft genome sequences of 28 En-terococcus sp. isolates. J. Bacteriol. 192:2469-2470.
34. Paulsen IT, et al. 2003. Role of mobile DNA in the evolution of vancomycin-resistant Enterococcus faecalis. Science 299:2071-2074.
35. Sajid A, et al. 2011. Phosphorylation of Mycobacterium tuberculosis Ser/ Thr phosphatase by PknA and PknB. PLoS One 6:e17871.
36. Lin WJ, et al. 2009. Threonine phosphorylation prevents promoter DNA binding of the Group B Streptococcus response regulator CovR. Mol. Microbiol. 71:1477-1495.
37. Ulijasz AT, Falk SP, Weisblum B. 2009. Phosphorylation of the RitR DNA-binding domain by a Ser-Thr phosphokinase: implications for global gene regulation in the streptococci. Mol. Microbiol. 71:382-390.
38. Andersson DI, Levin BR. 1999. The biological cost of antibiotic resistance. Curr. Opin. Microbiol. 2:489-493.
39. Foucault ML, Depardieu F, Courvalin P, Grillot-Courvalin C. 2010. Inducible expression eliminates the fitness cost of vancomycin resistance in enterococci. Proc. Natl. Acad. Sci. U. S. A. 107:16964-16969.
40. Kristich CJ, Chandler JR, Dunny GM. 2007. Development of a host-genotype-independent counterselectable marker and a high-frequency conjugative delivery system and their use in genetic analysis of Enterococ-cus faecalis. Plasmid 57:131-144.
41. Kristich CJ, Manias DA, Dunny GM. 2005. Development of a method for markerless genetic exchange in Enterococcus faecalis and its use in construction of a srtA mutant. Appl. Environ. Microbiol. 71:5837-5849.
42. Chen Y, Staddon JH, Dunny GM. 2007. Specificity determinants of conjugative DNA processing in the Enterococcus faecalis plasmid pCF10 and the Lactococcus lactis plasmid pRS01. Mol. Microbiol. 63:1549-1564.
43. Gold OG, Jordan HV, van Houte J. 1975. The prevalence of enterococci in the human mouth and their pathogenicity in animal models. Arch. Oral Biol. 20:473-477.
44. Dunny GM, Brown BL, Clewell DB. 1978. Induced cell aggregation and mating in Streptococcus faecalis: evidence for a bacterial sex pheromone. Proc. Natl. Acad. Sci. U. S. A. 75:3479-3483.
45. Maekawa S, Yoshioka M, Kumamoto Y. 1992. Proposal of a new scheme for the serological typing of Enterococcus faecalis strains. Microbiol. Immunol. 36:671-681.